
Videos














HER2+ Early-Stage Breast Cancer: Perioperative Approaches

Andrew Zhu, MD, PhD, director of Liver Cancer Research and Medicine at Massachusetts General Hospital, shares his advice on making decisions for frontline treatment of patients with hepatocellular carcinoma.







A Chemoimmunotherapeutic Approach to Nondriver NSCLC

Javier Pinilla-Ibarz, MD, PhD, senior member of the Department of Malignant Hematology at Moffitt Cancer Center, discusses the current treatment landscape of chronic lymphocytic leukemia.

<br /> Shilpa Gupta, MD, assistant professor in the Hematology, Oncology, and Transplantation Division at the University of Minnesota, discusses the potential for triplet regimens in the treatment of patients with renal cell carcinoma.






Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Oral Azacitidine-Cedazuridine Meets Pharmacokinetic Goal in Phase 3 MDS/CMML Trial
2
Q4 2026 Oncology Outlook: Key FDA Decisions to Watch
3
Bianchi Highlights Personalized Therapy as the Next Frontier in Myeloma and Amyloidosis
4
FDA Application Withdrawn for I-DXd in Small Cell Lung Cancer
5
